Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
  1. 4 Open-market buy Chief Scientific Officer bought 3,250 shares at $0.46 ($1,495)
  2. 4 Grant or award Director acquired 12,308 shares (grant or award)
  3. 4 Grant or award Director acquired 12,855 shares (grant or award)
  4. 4 Grant or award Director acquired 7,521 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Grant or award Director acquired 2,980 shares (grant or award)
  7. 4 Grant or award Director acquired 2,858 shares (grant or award)
  8. 4 Grant or award Director acquired 5,839 shares (grant or award)
  9. 4 Grant or award Director acquired 1,824 shares (grant or award)
  10. 4 Grant or award Director acquired 3,588 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market buy President & CEO bought 867 shares at $3.62 ($3,139)
  14. 4 Open-market buy Chief Medical Officer bought 639 shares at $3.62 ($2,313)
  15. 4 Open-market buy Chief Scientific Officer bought 1,163 shares at $3.62 ($4,210)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award Director acquired 1,414 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 4 Grant or award Director acquired 2,713 shares (grant or award)
  20. 4 Grant or award Director acquired 5,542 shares (grant or award)

Page 8 of 37 · 739 filings